Do heart benefits from diabetes drugs work equally well across different races?

When you take a medication for diabetes or weight, you want to know it will work for you. A large analysis of past clinical trials looked at whether a class of drugs called GLP-1 receptor agonists—medications like semaglutide and liraglutide—protect the heart equally well across different racial groups. The drugs clearly reduced the risk of major heart problems like heart attack and stroke in Asian and White adults with type 2 diabetes or overweight. The analysis suggests the benefit might be stronger for Asian adults, but the picture is less clear for Black adults, where the trend was similar but the result wasn't statistically significant. This means we can't yet say for sure what the heart benefit is for Black individuals based on this data alone. The analysis combined results from over 74,000 people, but the number of Black participants was much smaller than the White group, which can make it harder to detect a clear effect. It's an important step in asking whether treatments work the same for everyone, but more research focused on diverse populations is needed to get definitive answers.